Bausch Health CEO Joseph Papa will move over to head separate Bausch + Lomb pure-play eye health business and is preparing a team for either a spin-off or initial public offering of the unit in the third quarter, the executive said during a first quarter earning call 4 May. Papa said a sale of the division, which includes consumer health eye drops and dietary supplements, is also possible.
Bausch Health Companies Inc. CEO Joseph Papa told investors 4 May he plans to move with the Bausch & Lomb Inc. eye-care business that is being prepared for a spin-off, initial public offering or sale in the third quarter.
During the firm’s first quarter earnings presentation, Papa said he would continue as CEO of the newly segmented, pure-play eye...